Throughout 2021, the medical and scientific communities have focused on managing the
acute morbidity and mortality caused by the coronavirus disease 2019 (COVID-19) …

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). The ability of our cells to secrete type I …

Background Remdesivir improves clinical outcomes in patients hospitalized with moderate-
to-severe coronavirus disease 2019 (Covid-19). Whether the use of remdesivir in …

The COVID-19 pandemic brought about an increase in online shopping because of
government-imposed restrictions and consumer anxiety over the potential health risk …

Background: The long-term effects of COVID-19 remain largely unclear. This study aims to
investigate post-acute health consequences and mortality one year after hospital discharge …

OBJECTIVES: To describe the outcomes of hospitalized patients in a multicenter,
international coronavirus disease 2019 registry. DESIGN: Cross-sectional observational …

Background. COVID‐19 pandemic has become a global dilemma since December 2019.
Are the standard scores, such as acute physiology and chronic health evaluation (APACHE …

Background: This meta-analysis outlines the role of elevated lactate dehydrogenase (LDH)
levels in assessing the severity of coronavirus disease 2019 (COVID-19). Methods: The …

Objective We aimed to look at the burden of disease caused by SARS-COV-2 reinfections
and identified potential risk factors for disease severity. Methods We used national …

Children with Coronavirus disease 2019 (COVID-19) are being reported to have
manifestations of hyperinflammatory states and/or Kawasaki-like disease. In this study, we …